The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 28, 1995
Filed:
May. 13, 1994
Applicant:
Inventor:
Bradley C Pearce, East Hampton, CT (US);
Assignee:
Bristol-Myers Squibb Company, New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ; A61K / ;
U.S. Cl.
CPC ...
514486 ; 514 64 ; 514485 ; 514605 ; 514616 ; 514617 ; 514618 ; 514619 ; 514621 ; 514622 ; 514629 ; 514646 ; 514676 ; 514688 ; 514689 ; 514708 ; 514710 ; 514713 ; 514716 ; 514717 ; 514720 ; 514727 ; 514728 ; 514730 ; 514751 ; 514764 ; 514824 ; 560 24 ; 560 29 ; 560 30 ; 564-8 ; 564 99 ; 564155 ; 564157 ; 564158 ; 564161 ; 564162 ; 564163 ; 564167 ; 564169 ; 564170 ; 564175 ; 564176 ; 564177 ; 564183 ; 564218 ; 564223 ; 564305 ; 564440 ; 564442 ; 564443 ; 568-1 ; 568-2 ; 568-6 ; 568 27 ; 568 28 ; 568 30 ; 568 31 ; 568 32 ; 568 33 ; 568 35 ; 568 36 ; 568 37 ; 568 38 ; 568 39 ; 568 42 ; 568 43 ; 568 44 ; 568 45 ; 568 46 ; 568 51 ; 568 54 ; 568 55 ; 568 56 ; 568306 ; 568335 ; 568336 ; 568337 ; 568584 ; 568587 ; 568588 ; 568630 ; 568648 ; 568649 ; 568650 ; 568651 ; 568654 ; 568656 ; 568657 ; 568662 ; 568663 ; 568705 ; 568706 ; 568709 ; 568715 ; 568716 ; 568764 ; 568765 ; 568766 ; 568774 ; 568780 ; 568811 ; 568812 ; 568813 ; 570128 ; 570182 ; 585 24 ;
Abstract
This invention relates to structurally novel acyclic tocotrienol analogs, which are useful for cholesterol/lipid lowering in cases of hypercholesterolemia and hyperlipidemia, and for atherosclerosis. Also provided are pharmaceutical compositions and a method of use employing those compositions.